A mechanism for low penetrance in an ALS family with a novel SOD1 deletion

Zinman, L and Liu, HN and Sato, C and Wakutani, Y and Marvelle, AF and Moreno, D and Morrison, KE and Mohlke, KL and Bilbao, J and Robertson, J and Rogaeva, E (2009) A mechanism for low penetrance in an ALS family with a novel SOD1 deletion. Neurology, 72 (13). pp. 1153-1159. ISSN 0028-3878

URL of Published Version: http://dx.doi.org/10.1212/01.wnl.0000345363.65799.35

Identification Number/DOI: 10.1212/01.wnl.0000345363.65799.35

Abstract

Background: About 20% of familial amyotrophic lateral sclerosis (ALS) is caused by mutations in SOD1 and is typically transmitted as an autosomal dominant trait. However, due to reduced mutation penetrance, the disease may present in a recessive or sporadic manner. Objective: To determine the factors responsible for the low penetrance of the SOD1 mutation. Methods: Twelve members of a Canadian ALS family of Filipino origin were recruited for the study. SOD1 was sequenced in the proband. SOD1 expression was assessed by real-time-PCR and immunoblotting. Results: The proband was a homozygous carrier of a novel 6 bp deletion in exon 2 (Delta G27/P28), the pathologic significance of which was confirmed by immunohistochemistry. Eight living family members are heterozygotes and remain unaffected at ages ranging between 48 and 85 years. Haplotype analysis showed that the deletion is a single founder mutation likely common in the Cagayan province (Philippines). The low penetrance of the mutation is explained by the fact that it enhances the naturally occurring alternative splicing of exon 2 of the SOD1 mRNA, leading to reduced transcription of the mutant allele. Indeed, Western blot analysis demonstrated the low level of SOD1 protein in carriers of the Delta G27/P28 compared to wild-type individuals or a carrier of the A4V SOD1 mutation. Conclusion: The enhanced splicing of exon 2 acts as a natural knock-down of the mutant SOD1 allele in the Filipino amyotrophic lateral sclerosis (ALS) family. There is a need for careful investigation of splicing isoforms of SOD1 and other ALS genes as factors influencing the severity of disease. Neurology (R) 2009; 72: 1153-1159

Type of Work:Article
School/Faculty:Colleges (2008 onwards) > College of Medical & Dental Sciences
Department:Neuropharmacology and Neurobiology
Projects:US Muscular Dystrophy Association Project title not known
Krembil Scientific Development Seed Fund (E.R.
J.R.
L.Z.)
Japan-Canada Project title not known
Canadian Institutes of Health Research (CIHR) Project title not known
ALS Society of Canada Project title not known
Temerty Family Foundation (L.Z.) Project title not known
American ALS Association Project title not known
Funders:US Muscular Dystrophy Association
Temerty Family Foundation (L.Z.)
Krembil Scientific Development Seed Fund (E.R.
J.R.
L.Z.)
Japan-Canada
ALS Society of Canada
Canadian Institutes of Health Research (CIHR)
American ALS Association
Subjects:R Medicine > RC Internal medicine > RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry
ID Code:65804

If the "URL of Published Version" above does not provide full text, click here to search for an alternative UoB-subscribed service using FindIt@Bham

Edit Item (Staff only)